| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |